Balance Labs, Inc.
For the period ended Dec 31, 2025. Filed Apr 10, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Apr 10, 2026
BLNCStored price and day change unavailable
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement Schedules
| 1. | Consolidated Financial Statements |
The financial statements are included in Item 8. “Consolidated Financial Statements and Supplementary Data.”
| 2. | Consolidated Financial Statement Schedules |
All schedules are omitted as information required is inapplicable or the information is presented in the consolidated financial statements and the related notes.
| 3. | Exhibits |
The following is a list of exhibits filed with this Annual Report incorporated herein by reference (numbered in accordance with Item 601 of Regulation S-K):
| Exhibit No. | Title |
| 3.1 | Certificate of Incorporation (incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on March 24, 2015) |
| 3.2 | By-laws (incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on March 24, 2015) |
| 4.2 | 10% Convertible Debenture by and between the Company and Newel dated April 1, 2016 (incorporated by reference to the Current Report on Form 8-K filed with the SEC on April 8, 2016.) |
| 4.3 | Warrant to Purchase Common Stock by and between the Company and Newel dated April 1, 2016 (incorporated by reference to the Current Report on Form 8-K filed with the SEC on April 8, 2016.) |
| 4.4 | Description of Securities (incorporated by reference to the Annual Report on Form 10-K filed with the SEC on March 31, 2022.) |
| 4.5 | Convertible Promissory Note dated June 28, 2021 (incorporated by reference to the Quarterly Report on Form 10-Q filed with the SEC on November 19, 2021.) |
| 10.1 | Consulting Agreement between Michael Farkas and the Company dated February 6, 2015 (incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on March 24, 2015) |
| 10.2 | Service Agreement between Bang Holdings Corp. and the Company dated August 22, 2014 (incorporated by reference to the Registration Statement on Form S-1 filed with the SEC on March 24, 2015) |
| 10.3 | Form of Securities Purchase Agreement dated September 17, 2015, by and between Balance Labs, Inc. and certain investors (incorporated by reference to the Quarterly Report on Form 10-Q filed with the SEC on November 16, 2015.) |
| 10.4 | Investment Agreement by and between the Company and Newel dated April 1, 2016 (incorporated by reference to the Current Report on Form 8-K filed with the SEC on April 8, 2016.) |
| 10.5 | Registration Rights Agreement by and between the Company and Newel dated April 1, 2016 (incorporated by reference to the Current Report on Form 8-K filed with the SEC on April 8, 2016.) |
| 10.6 | Promissory Note between Four Acquisitions Tech LTD and Balance Labs, Inc. dated September 30, 2021 (incorporated by reference to the Annual Report on Form 10-K filed with the SEC on March 31, 2022.) |
| 10.7 | Promissory Note between Four Acquisitions Tech Ltd. and Balance Labs, Inc. dated January 29, 2021 (incorporated by reference to the Annual Report on Form 10-K filed with the SEC on March 31, 2022.) |
| 10.8 | Form of Promissory note (incorporated by reference to the Annual Report on Form 10-K filed with the SEC on March 31, 2022.) |
| 10.9 | CEO Employment Agreement between Alan Campbell and Balance Labs, Inc. executed August 22, 2025 (incorporated by reference to the Current Report on Form 8-K filed with the SEC on August 29, 2025.) |
| 10.10 | President Offer Letter, executed February 6, 2026 (incorporated by reference to the Current Report on Form 8-K filed with the SEC on February 11, 2026.) |
| 21.1 | List of Subsidiaries (incorporated by reference to the Annual Report on Form 10-K filed with the SEC on May 28, 2020.) |
| 31.1 | Certification of principal executive officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002* |
| 31.2 | Certification of principal financial officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002* |
| 32.1 | Certification of principal executive officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002** |
| 32.2 | Certification of principal financial officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002** |
| 97.1 | Balance Labs, Inc. Clawback Policy (incorporated by reference to the Annual Report on Form 10-K filed with the SEC on April 15, 2024.) |
| 101.INS | Inline XBRL Instance Document* |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document* |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document* |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document* |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document* |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document* |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |
| * | Filed herewith |
|---|---|
| ** | Exhibits 32.1 and 32.2 are being furnished and shall not be deemed to be “filed” for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall such exhibits be deemed to be incorporated by reference in any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as otherwise specifically stated in such filing. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.